Research progress on relationship of different dietary patterns with risk of atrial fibrillation
-
摘要:
心房颤动(房颤)是最常见的室上性心律失常, 具有高发病率和高致死率的特点。房颤的发生机制尚未完全清楚, 目前仍缺少有效的根治手段。因此, 房颤的预防就尤为重要。不同的饮食模式与房颤的发生和发展关系密切。本研究对包括地中海饮食、终止高血压的饮食(得舒饮食)、鱼类和ω-3多不饱和脂肪酸、橄榄油、坚果、咖啡因、巧克力、酒精、油炸食品和盐等不同饮食因素与房颤发生的关系进行综述, 并探讨其作用机制。
Abstract:Atrial fibrillation (AF) is the most common supraventricular arrhythmia, characterized by high morbidity and mortality.The mechanism of AF is not very clear, and there is still a lack of effective radical treatments.Therefore, the prevention of AF is particularly important.Different dietary patterns are closely related to the occurrence and development of AF.This study reviewed the relationships of different dietary factors such as the Mediterranean diet, the Dietary Approaches to Stop Hypertension (DASH diet), fish and ω-3 polyunsaturated fatty acids, olive oil, nuts, caffeine, chocolate, alcohol, fried food and salt with the occurrence of AF, and explored its mechanism of action.
-
胫骨骨折是比较常见的骨折类型，约占四肢骨折的3.77%, 占全身骨折的9.45%[1]。由于胫骨解剖位置的特殊性，外力高能量冲击如交通意外、高处坠落、摔倒等容易造成应力集中，导致血运破坏和软组织损伤，若处理不当，不仅骨折愈合困难，而且易发生感染、畸形愈合等并发症。A型闭合性胫骨远端骨折是胫骨骨折的常见类型，根据胫骨干骺端的粉碎程度可分为A1、A2和A3 3个亚型。经皮微创钢板内固定术(MIPPO)是目前治疗此类骨折的主要术式，为骨折愈合提供生物学环境，临床应用广泛[2]，但受软组织条件较差和血运破坏等影响，患者术后并发症仍难以避免，引起临床思考最佳钢板放置的位置(胫骨内侧或外侧)[3], 但目前并未形成统一定论，相关研究报道也较少。本研究对88例A型闭合性胫骨远端骨折开展前瞻性随机分组对照试验，探讨内侧和外侧MIPPO的短期手术疗效，为临床术式选择提供参考，现报告如下。
1. 资料与方法
1.1 一般资料
纳入本院2016年2月—2019年6月收治的88例A型闭合性胫骨远端骨折患者，纳入标准: 经X线、CT等影像学检查，并参考AO分型标准确诊为A型闭合性胫骨远端骨折，未见其他骨折部位; 患者年龄18~65岁，精神意识正常，配合研究并愿意接受随访，签署研究知情同意书。排除标准: 病理性骨折、代谢性或内分泌性骨病、严重外伤或骨质疏松; 合并肝、肾功能不全，免疫系统缺陷，严重心脑血管疾病，糖尿病足或恶性肿瘤者; 哺乳期妊娠期妇女; 入院前接受过相关治疗者。采用简单随机分组法分为内侧固定组和外侧固定组，各44例。内侧固定组男29例，女15例; 年龄21~63岁，平均(41.25±10.34)岁; AO分型: A1型(单纯型)20例, A2型(粉碎型)13例, A3型(严重粉碎型)11例; 骨折发生原因: 交通意外伤17例，运动意外伤14例，砸伤8例，坠落伤5例; 骨折发生至接受手术时间2~11 d, 平均(3.59±1.02) d; 合并腓骨骨折19例。外侧固定组男31例，女13例; 年龄21~63岁，平均年龄(39.25±10.34)岁; AO分型: A1型19例, A2型15例, A3型(严重粉碎型)10例; 骨折发生至接受手术时间1~12 d, 平均(3.61±1.03) d; 合并腓骨骨折17例。2组胫骨远端骨折患者上述资料分布均衡，组间比较差异无统计学意义(P>0.05)。本研究获得医院伦理学委员会批准。
1.2 方法
所有患者入院后均接受抗炎消肿等对症治疗，待骨折处皮肤出现褶皱后行MIPPO技术联合LCP内固定术治疗，手术均由本院骨伤科具有3年以上经验的外科医师操作，围术期护理均相同。术前常规持续硬膜外麻醉，取仰卧位，合并腓骨骨折者先行复位和腓骨远端解剖钢板内固定处理，恢复患肢长度。
内侧固定组：自内踝尖下0.5 cm处行长度约3 cm的弧形切口，骨膜剥离器沿胫骨方向推开软组织，在骨膜和皮下组织间建立软组织隧道，选择合适型号的钢板沿隧道插入，钢板远端位于内踝尖近端约1 cm处，由远端至近端置入螺钉。在C型臂X线机透视下对骨折端进行手法复位，复位完毕后，将钢板剩余各孔进行体表定位，采用锁定螺钉固定远近端钉孔，固定完毕后透视下观察骨折端对位、螺钉长度等是否满意，内固定后常规冲洗缝合切口，放置引流管。
外侧固定组：于踝关节面胫骨嵴外侧旁约1 cm处做长度4~5 cm纵向切口，分离软组织，钝性分离胫骨前肌外侧缘至骨面，向外侧缘紧贴骨面进行剥离，建立软组织隧道，由远端至近端插入合适型号钢板，近端显露钉孔，在C型臂X线机透视下对钢板剩余孔钉行螺钉固定，然后冲洗缝合切口，术后处理同内侧固定组。2组患者术后均抬高患肢，术后使用抗生素预防感染并止痛消肿治疗，在医师指导下接受循序渐进的康复锻炼治疗，术后均通过门诊复查形式随访至少6个月。
1.3 观察指标
统计2组患者手术时间、手术出血量、术后1 d视觉模拟评分法(VAS)评分、骨折愈合时间等，其中VAS评分为患者自评，总分0~10分，根据主观疼痛感受进行赋值评分，评分越高表示疼痛越明显，反之愈轻。骨折愈合标准: ①患肢可完全负重，无局部疼痛; ② X线检查提示有连续骨痂线通过骨折断端，同时满足①、②表示骨折愈合。术后末次随访行踝-后足功能AOFAS评分, AOFAS评分总分100分, 75分为合格，得分越高表示踝-后足功能恢复越好。2组术后随访期间记录手术并发症情况。
1.4 统计学分析
采用SPSS 20.0软件分析数据，计数资料采用[n(%)]表示，组间比较行χ2检验; 计量资料满足正态分布和方差齐性采用(x±s)表示，组间比较行独立t检验，同组不同时点数据比较行配对t检验。P < 0.05为差异有统计学意义。
2. 结果
2.1 2组临床手术指标比较
内侧固定组手术时间、手术出血量和骨折愈合时间均优于外侧固定组，差异有统计学意义(P < 0.05), 2组术后1 d VAS评分比较，差异无统计学意义(P>0.05), 见表 1。
表 1 2组患者临床手术指标比较(x±s)指标 内侧固定组
(n=44)外侧固定组
(n=44)手术时间/min 64.28±8.57* 85.16±10.93 手术出血量/mL 54.02±10.42* 82.18±15.07 术后1 d VAS评分/分 3.21±0.65 3.36±0.81 骨折愈合时间/月 5.01±0.94* 5.48±1.13 VAS: 视觉模拟评分法。与外侧固定组比较, *P < 0.05。 2.2 2组术后随访并发症及末次随访AOFAS评分比较
2组术后均成功随访≥6个月，内侧固定组随访6~10个月，平均8.35个月。外侧固定组随访6~9个月，平均8.29个月。术后并发症有切口感染、钢板弯曲、延迟愈合和踝关节疼痛，均无钢板断裂和畸形愈合发生。切口感染者经3~4次换药和抗感染治疗后愈合。钢板弯曲和骨折延迟愈合者嘱咐患肢不负重，石膏固定后逐渐愈合。踝关节疼痛者摘除钢板后疼痛缓解。2组切口感染、钢板弯曲、延迟愈合、踝关节疼痛及总并发症发生率比较，差异均无统计学意义(P>0.05), 末次随访AOFAS评分比较差异亦无统计学意义(P>0.05), 见表 2。
表 2 2组患者随访并发症和AOFAS评分比较(x±s)[n(%)]组别 n 并发症 AOFAS评分/分 切口感染 钢板弯曲 延迟愈合 踝关节疼痛 合计 内侧固定组 44 3(6.82) 0 1(2.27) 2(4.55) 6(13.64) 86.24±7.35 外侧固定组 44 2(4.55) 1(2.27) 2(4.55) 3(6.82) 8(18.18) 85.38±7.51 3. 讨论
MIPPO是目前治疗胫骨远端骨折的有效术式，优点在于可避免暴露骨折部位，保留骨折部位血运，促进骨折愈合，同时减少并发症[4]。董磊等[5-6]报道, MIPPO技术能最大程度保护软组织和骨皮质，促进骨折愈合。临床经验表明，内侧或外侧MIPPO均具有显著疗效，患者术后骨折愈合率高，足部疼痛和前后足活动功能均有明显改善，但不同固定方法MIPPO的手术效果比较尚需大量研究论证。朱兴建等[7]报道指出, LCP应用MIPPO技术治疗胫骨远端骨折，与内侧入路比较，外侧入路术并发症率更低，手术时间、出血量和畸形愈合率也明显减少。但石伟哲等[8]报道显示，内侧或外侧MIPPO治疗A型闭合性胫骨远端骨折的短期疗效并无显著差异。
本研究显示, 2组患者术后1 d VAS评分比较无显著差异，但内侧固定组在手术时间、手术出血量和骨折愈合时间方面更具优势(P < 0.05), 与文献报道[10]相似，说明内侧固定能显著缩短MIPPO手术时间和骨折愈合时间，减少手术出血量。分析原因认为，胫骨远端钢板外侧固定虽然能改善软组织覆盖条件，减少软组织并发症发生，但此固定方法对软组织的剥离程度较严重，而且术中需要严格保护腓深神经和胫骨前动脉，造成手术时间延长和出血量增多，增加患者手术生理痛苦[11]。相比而言，胫骨内侧放置钢板操作更加简单，缩短了手术时间，减少出血量，缓解患者手术不适感，而且胫骨内侧固定更符合“生物学固定”原则，钢板与肌群张力相互平衡，营造理想的生物力学生理环境。有研究[12-13]指出，置入胫骨外侧的钢板易受外侧、后侧的肌肉牵拉作用，骨折部向内侧成角，造成愈合延迟和踝关节疼痛，严重时发生钢板断裂和畸形愈合。此外，相对外侧固定，内侧固定对局部血运的破坏较小，钢板置于胫骨内侧能有效保护外侧骨膜血管系统，促进骨折愈合和术后功能恢复[14]。本研究随访显示, 2组术后均无钢板断裂和畸形愈合等严重并发症发生，组间切口感染、钢板弯曲、延迟愈合和踝关节疼痛发生率比较无显著差异(P>0.05), 且末次随访踝-足功能均恢复良好, AOFAS评分比较无显著差异，提示MIPPO术中采用2种固定方法的短期疗效和并发症率接近[15]。
本研究也存在研究准备仓促、纳入样本量偏少、随访期偏短以及缺乏影像学测量数据等不足。此外, MIPPO手术疗效还受软组织损伤程度、术后康复锻炼情况等因素影响，对本研究结论可能造成一定偏倚，在后续研究中需进一步完善。总之，内侧或外侧MIPPO治疗A型闭合性胫骨远端骨折均安全有效，但胫骨内侧放置钢板固定手术操作简单，可节约手术时间，减少出血量，缩短骨折愈合时间，促进患者术后尽快康复，而且更符合骨折愈合的生物力学环境，建议临床优先选择内侧固定方法。
-
[1] HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. doi: 10.1093/eurheartj/ehaa612
[2] 中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动: 目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志, 2022, 26(1): 15-88. doi: 10.3760/cma.j.cn113859-20211224-00264 [3] HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498. doi: 10.1093/eurheartj/ehaa612
[4] ZHOU Z Q, HU D Y. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China[J]. J Epidemiol, 2008, 18(5): 209-216. doi: 10.2188/jea.JE2008021
[5] DU X, GUO L Z, XIA S J, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7): 535-541. doi: 10.1136/heartjnl-2020-317915
[6] GAO P, GAO X Y, XIE B X, et al. Aging and atrial fibrillation: a vicious circle[J]. Int J Cardiol, 2024, 395: 131445. doi: 10.1016/j.ijcard.2023.131445
[7] ELLIOTT A D, MIDDELDORP M E, VAN GELDER I C, et al. Epidemiology and modifiable risk factors for atrial fibrillation[J]. Nat Rev Cardiol, 2023, 20(6): 404-417. doi: 10.1038/s41569-022-00820-8
[8] BICCIRÈF G, BUCCI T, MENICHELLI D, et al. Mediterranean diet: a tool to break the relationship of atrial fibrillation with the metabolic syndrome and non-alcoholic fatty liver disease[J]. Nutrients, 2022, 14(6): 1260. doi: 10.3390/nu14061260
[9] MATTIOLI A V, MILORO C, PENNELLA S, et al. Adherence to Mediterranean diet and intake of antioxidants influence spontaneous conversion of atrial fibrillation[J]. Nutr Metab Cardiovasc Dis, 2013, 23(2): 115-121. doi: 10.1016/j.numecd.2011.03.005
[10] TU S J, GALLAGHER C, ELLIOTT A D, et al. Associations of dietary patterns, ultra-processed food and nutrient intake with incident atrial fibrillation[J]. Heart, 2023, 109(22): 1683-1689. doi: 10.1136/heartjnl-2023-322412
[11] PASTORI D, CARNEVALE R, MENICHELLI D, et al. Is there an interplay between adherence to Mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients?[J]. Antioxid Redox Signal, 2016, 25(14): 751-755. doi: 10.1089/ars.2016.6839
[12] PASTORI D, CARNEVALE R, NOCELLA C, et al. Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: effect of adherence to Mediterranean diet[J]. J Am Heart Assoc, 2017, 6(6): e005784. doi: 10.1161/JAHA.117.005784
[13] PIGNATELLI P, PASTORI D, FARCOMENI A, et al. Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients[J]. Clin Nutr, 2015, 34(5): 899-903. doi: 10.1016/j.clnu.2014.09.011
[14] BLACKBURN G L. Functional foods in the prevention and treatment of disease: significance of the Dietary Approaches to Stop Hypertension Study[J]. Am J Clin Nutr, 1997, 66(5): 1067-1071. doi: 10.1093/ajcn/66.5.1067
[15] NINIO D M, MURPHY K J, HOWE P R, et al. Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model[J]. J Cardiovasc Electrophysiol, 2005, 16(11): 1189-1194. doi: 10.1111/j.1540-8167.2005.50007.x
[16] WU J H, LEMAITRE R N, KING I B, et al. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study[J]. Circulation, 2012, 125(9): 1084-1093. doi: 10.1161/CIRCULATIONAHA.111.062653
[17] KHAWAJA O, GAZIANO J M, DJOUSSÉ L. A meta-analysis of omega-3 fatty acids and incidence of atrial fibrillation[J]. J Am Coll Nutr, 2012, 31(1): 4-13. doi: 10.1080/07315724.2012.10720003
[18] MARIANI J, DOVAL H C, NUL D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials[J]. J Am Heart Assoc, 2013, 2(1): e005033. doi: 10.1161/JAHA.112.005033
[19] LI F R, CHEN G C, QIN J B, et al. DietaryFish and long-chain n-3 polyunsaturated fatty acids intake and risk of atrial fibrillation: a meta-analysis[J]. Nutrients, 2017, 9(9): 955. doi: 10.3390/nu9090955
[20] RIX T A, JOENSEN A M, RIAHI S, et al. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study[J]. Europace, 2014, 16(11): 1554-1561. doi: 10.1093/europace/euu019
[21] QIAN F, TINTLE N, JENSEN P N, et al. Omega-3 fatty acid biomarkers andIncident atrial fibrillation[J]. J Am Coll Cardiol, 2023, 82(4): 336-349. doi: 10.1016/j.jacc.2023.05.024
[22] MYHRE P L, BERGE T, KALSTAD A A, et al. Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': a secondary analysis from the OMEMI trial[J]. Clin Nutr, 2023, 42(9): 1657-1660. doi: 10.1016/j.clnu.2023.07.002
[23] SHEN J, JOHNSON V M, SULLIVAN L M, et al. Dietary factors and incident atrial fibrillation: the Framingham Heart Study[J]. Am J Clin Nutr, 2011, 93(2): 261-266. doi: 10.3945/ajcn.110.001305
[24] MARTÍNEZ-GONZÁLEZ M Á, TOLEDO E, ARÓS F, et al. Extravirgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevención con Dieta Mediterránea) trial[J]. Circulation, 2014, 130(1): 18-26. doi: 10.1161/CIRCULATIONAHA.113.006921
[25] SAGRIS M, VARDAS E P, THEOFILIS P, et al. Atrial fibrillation: pathogenesis, predisposing factors, and genetics[J]. Int J Mol Sci, 2021, 23(1): 6. doi: 10.3390/ijms23010006
[26] RUIZ-CANELA M, GUASCH-FERRÉ M, RAZQUIN C, et al. Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study[J]. Rev Esp Cardiol, 2022, 75(8): 649-658. doi: 10.1016/j.recesp.2021.10.005
[27] LARSSON S C, DRCA N, BJÖRCK M, et al. Nut consumption and incidence of seven cardiovascular diseases[J]. Heart, 2018, 104(19): 1615-1620. doi: 10.1136/heartjnl-2017-312819
[28] KHAWAJA O, GAZIANO J M, DJOUSSE L. Nut consumption and risk of atrial fibrillation in the Physicians'Health Study[J]. Nutr J, 2012, 11: 17. doi: 10.1186/1475-2891-11-17
[29] BALAKRISHNA R, BJØRNERUD T, BEMANIAN M, et al. Consumption of nuts and seeds and health outcomes including cardiovascular disease, diabetes and metabolic disease, cancer, and mortality: an umbrella review[J]. Adv Nutr, 2022, 13(6): 2136-2148. doi: 10.1093/advances/nmac077
[30] BHAVE P D, HOFFMAYER K. Caffeine and atrial fibrillation: friends or foes[J]. Heart, 2013, 99(19): 1377-1378. doi: 10.1136/heartjnl-2013-304543
[31] BODAR V, CHEN J Y, GAZIANO J M, et al. Coffee consumption and risk of atrial fibrillation in the physicians' health study[J]. J Am Heart Assoc, 2019, 8(15): e011346. doi: 10.1161/JAHA.118.011346
[32] BAZAL P, GEA A, NAVARRO A M, et al. Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts[J]. Eur J Prev Cardiol, 2021, 28(6): 648-657. doi: 10.1177/2047487320909065
[33] CONEN D, CHIUVE S E, EVERETT B M, et al. Caffeine consumption and incident atrial fibrillation in women[J]. Am J Clin Nutr, 2010, 92(3): 509-514. doi: 10.3945/ajcn.2010.29627
[34] MOSTOFSKY E, JOHANSEN M B, LUNDBYE-CHRISTENSEN S, et al. Risk of atrial fibrillation associated with coffee intake: findings from the Danish Diet, Cancer, and Health study[J]. Eur J Prev Cardiol, 2016, 23(9): 922-930. doi: 10.1177/2047487315624524
[35] CHIENG D, CANOVAS R, SEGAN L, et al. The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank[J]. Eur J Prev Cardiol, 2022, 29(17): 2240-2249. doi: 10.1093/eurjpc/zwac189
[36] MATTIOLI A V, FARINETTI A, MILORO C, et al. Influence of coffee and caffeine consumption on atrial fibrillation in hypertensive patients[J]. Nutr Metab Cardiovasc Dis, 2011, 21(6): 412-417. doi: 10.1016/j.numecd.2009.11.003
[37] CASIGLIA E, TIKHONOFF V, ALBERTINI F, et al. Caffeine intake reduces incident atrial fibrillation at a population level[J]. Eur J Prev Cardiol, 2018, 25(10): 1055-1062. doi: 10.1177/2047487318772945
[38] MOSTOFSKY E, BERG JOHANSEN M, TJØNNELAND A, et al. Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study[J]. Heart, 2017, 103(15): 1163-1167. doi: 10.1136/heartjnl-2016-310357
[39] KHAWAJA O, PETRONE A B, KANJWAL Y, et al. Chocolate consumption and risk of atrial fibrillation (from the physicians' health study)[J]. Am J Cardiol, 2015, 116(4): 563-566. doi: 10.1016/j.amjcard.2015.05.009
[40] LARSSON S C, VIRTAMO J, WOLK A. Chocolate consumption and risk of stroke in women[J]. J Am Coll Cardiol, 2011, 58(17): 1828-1829. doi: 10.1016/j.jacc.2011.07.023
[41] LARSSON S C, DRCA N, JENSEN-URSTAD M, et al. Chocolate consumption and risk of atrial fibrillation: two cohort studies and a meta-analysis[J]. Am Heart J, 2018, 195: 86-90. doi: 10.1016/j.ahj.2017.09.013
[42] DJOUSSÉL, LEVY D, BENJAMIN E J, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study[J]. Am J Cardiol, 2004, 93(6): 710-713. doi: 10.1016/j.amjcard.2003.12.004
[43] LARSSON S C, DRCA N, WOLK A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis[J]. J Am Coll Cardiol, 2014, 64(3): 281-289. doi: 10.1016/j.jacc.2014.03.048
[44] MIDDELDORP M E, SANDHU R K, MAO J, et al. Risk factors for the development of new-onset persistent atrial fibrillation: subanalysis of the VITAL study[J]. Circ Arrhythm Electrophysiol, 2023, 16(12): 651-662. doi: 10.1161/CIRCEP.123.012334
[45] LI X F, LIU Z Y, JIANG X C, et al. Global, regional, and national burdens of atrial fibrillation/flutter from 1990 to 2019: an age-period-cohort analysis using the Global Burden of Disease 2019 study[J]. J Glob Health, 2023, 13: 04154. doi: 10.7189/jogh.13.04154
[46] GRINDAL A W, SPARROW R T, MCINTYRE W F, et al. Alcohol consumption and atrial arrhythmia recurrence after atrial fibrillation ablation: a systematic review and meta-analysis[J]. Can J Cardiol, 2023, 39(3): 266-273. doi: 10.1016/j.cjca.2022.12.010
[47] FREDERIKSEN T C, CHRISTIANSEN M K, BENJAMIN E J, et al. Five-year changes in alcohol intake and risk of atrial fibrillation: a Danish cohort study[J]. Eur J Prev Cardiol, 2023, 30(11): 1046-1053. doi: 10.1093/eurjpc/zwac293
[48] LEE J W, ROH S Y, YOON W S, et al. Changes in alcohol consumption habits and risk of atrial fibrillation: a nationwide population-based study[J]. Eur J Prev Cardiol, 2024, 31(1): 49-58. doi: 10.1093/eurjpc/zwad270
[49] GALLAGHER C, HENDRIKS J M L, MAHAJAN R, et al. Lifestyle management to prevent and treat atrial fibrillation[J]. Expert Rev Cardiovasc Ther, 2016, 14(7): 799-809. doi: 10.1080/14779072.2016.1179581
[50] MARCUS G M, SMITH L M, WHITEMAN D, et al. Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period[J]. Pacing Clin Electrophysiol, 2008, 31(3): 266-272. doi: 10.1111/j.1540-8159.2008.00985.x
[51] SPAAK J, TOMLINSON G, MCGOWAN C L, et al. Dose-related effects of red wine and alcohol on heart rate variability[J]. Am J Physiol Heart Circ Physiol, 2010, 298(6): H2226-H2231. doi: 10.1152/ajpheart.00700.2009
[52] VOSKOBOINIK A, WONG G, LEE G, et al. Moderate alcohol consumption is associated with atrial electrical and structural changes: insights from high-density left atrial electroanatomic mapping[J]. Heart Rhythm, 2019, 16(2): 251-259. doi: 10.1016/j.hrthm.2018.10.041
[53] BACZKÓI, LIGHT P E. Resveratrol and derivatives for the treatment of atrial fibrillation[J]. Ann N Y Acad Sci, 2015, 1348(1): 68-74. doi: 10.1111/nyas.12843
[54] STEPHAN L S, ALMEIDA E D, MARKOSKI M M, et al. Red wine, resveratrol and atrial fibrillation[J]. Nutrients, 2017, 9(11): 1190. doi: 10.3390/nu9111190
[55] KHAWAJA O, SESSO H D, CHEN J Y, et al. Consumption of fried foods and risk of atrial fibrillation in the Physicians'Health Study[J]. Eur J Nutr, 2020, 59(3): 935-940. doi: 10.1007/s00394-019-01952-3
[56] WUOPIO J, ORHO-MELANDER M, ÄRNLÖV J, et al. Estimated salt intake and risk of atrial fibrillation in a prospective community-based cohort[J]. J Intern Med, 2021, 289(5): 700-708. doi: 10.1111/joim.13194
[57] LI N, WANG L, LI L, et al. The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives[J]. Mil Med Res, 2023, 10(1): 51.
[58] GAWAŁKO M, AGBAEDENG T A, SALJIC A, et al. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications[J]. Cardiovasc Res, 2022, 118(11): 2415-2427. doi: 10.1093/cvr/cvab292
下载:
计量
- 文章访问数: 0
- HTML全文浏览量: 0
- PDF下载量: 0
苏公网安备 32100302010246号